1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Past deadline referenced was March 16 for rare CNS/cardiovascular/immunological disease projects; no open calls currently.
Funding for drug-discovery projects on ultrarare diseases is sponsored by RTW Foundation. The RTW Foundation focuses on funding drug-discovery projects for diseases that affect fewer than 1000 people worldwide and for which no commercial drug-development program exists. Proposals co-developed by rare disease foundations and Rare Disease Advisors are prioritized.
Ornithine Transcarbamylase Deficiency (OTCD) is an ultrarare disease.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Rare disease foundations interested in developing therapies for their patients, co-developing proposals with Rare Disease Advisors. Confirm the full requirements in the official notice before applying.
Funding for drug-discovery projects on ultrarare diseases is funded by RTW Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program